Low level amplification of c-sis and c-myc in a spontaneous osteosarcoma model.
Canine and human osteosarcoma are very similar clinically, radiologically and pathologically. DNA extracted from canine osteosarcomas (n = 9) and normal canine control tissues (n = 17) was examined for amplification of the c-sis, c-myc, N-myc and c-H-ras protooncogenes. Statistically significant amplification of the c-sis and c-myc protooncogenes was evident in the tumor tissues as compared to the normal control tissues (P less than 0.05). DNA and total cellular RNA from cultured canine and human osteosarcoma and fibroblast cell lines were examined for amplification or enhanced expression of c-sis and c-myc. Very low levels of c-myc and c-sis DNA amplification were noted in canine osteosarcoma cells as compared to canine fibroblasts. Immunostaining of sections of human and canine osteosarcoma for the sis gene product, PDGF B, showed similar levels and patterns of expression in both populations of tumors.
Department of Veterinary Physiology and Pharmacology, College of Veterinary Medicine, Texas A and M University, College Station 77843.
D T
DT
Kochevar
J
J
Kochevar
L
L
Garrett
D000818:Animals; D015139:Blotting, Southern; D004283:Dog Diseases / Q000235:genetics*; D004285:Dogs; D005784:Gene Amplification; D016259:Genes, myc; D011905:Genes, ras; D007124:Immunoenzyme Techniques; D009857:Oncogenes; D012516:Osteosarcoma / Q000235:genetics / Q000662:veterinary*; D010982:Platelet-Derived Growth Factor / Q000235:genetics / Q000378:metabolism*; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics*; D011519:Proto-Oncogenes
D010982:Platelet-Derived Growth Factor; D016271:Proto-Oncogene Proteins c-myc